(Q34463976)

2 August 2017

Agonistic properties of cannabidiol at 5-HT1a receptors (English)

1 reference

2 August 2017

0 references

0 references

Ethan B Russo

1

0 references

author name string

Andrea Burnett

series ordinal

2

1 reference

2 August 2017

Brian Hall

series ordinal

3

1 reference

2 August 2017

Keith K Parker

series ordinal

4

1 reference

2 August 2017

1 August 2005

1 reference

2 August 2017

Neurochemical Research

1 reference

2 August 2017

30

1 reference

2 August 2017

1037-1043

1 reference

2 August 2017

8

1 reference

https://scigraph.springernature.com/pub.10.1007/s11064-005-6978-1

2 August 2017

0 references

cites work

Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?

1 reference

12 December 2020

Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial

1 reference

12 December 2020

Pharmacology of cannabinoid CB1 and CB2 receptors.

1 reference

12 December 2020

Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients

1 reference

12 December 2020

Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of delta9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors

1 reference

12 December 2020

Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants

1 reference

12 December 2020

Modulation of cannabinoid agonist binding by 5-HT in the rat cerebellum

1 reference

12 December 2020

Psychopharmacology of 5-HT(1A) receptors.

1 reference

12 December 2020

Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors.

1 reference

12 December 2020

Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans.

1 reference

12 December 2020

Activity of Parthenolide at 5HT2A receptors.

1 reference

12 December 2020

Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells

1 reference

12 December 2020

Structural variants of a human 5-HT1a receptor intracellular loop 3 peptide

1 reference

12 December 2020

Hallucinogens and serotonergic mechanisms

1 reference

12 December 2020

Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex

1 reference

12 December 2020

A review of central 5-HT receptors and their function

1 reference

12 December 2020

Hypnotic and antiepileptic effects of cannabidiol.

1 reference

12 December 2020

The effect of in vivo treatment with (-) delta 1-tetrahydrocannabinol, and other psychoactive drugs on the in vitro uptake of biogenic amines

1 reference

12 December 2020

Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide

1 reference

12 December 2020

A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms

1 reference

12 December 2020

Initial experiences with medicinal extracts of cannabis for chronic pain: results from 34 'N of 1' studies

1 reference

12 December 2020

Cannabidiol interferes with the effects of Δ9-tetrahydrocannabinol in man

1 reference

12 December 2020

Effect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults

1 reference

12 December 2020

Cannabinoid receptors are absent in insects

1 reference

12 December 2020

Comparative receptor binding analyses of cannabinoid agonists and antagonists.

1 reference

12 December 2020

5-HT1 receptors in migraine pathophysiology and treatment

1 reference

12 December 2020

The genomic clone G-21 which resembles a beta-adrenergic receptor sequence encodes the 5-HT1A receptor

1 reference

12 December 2020

Cannabis is more than simply delta(9)-tetrahydrocannabinol

1 reference

12 December 2020

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

12 December 2020

[3H]spiroxatrine labels a serotonin1A-like site in the rat hippocampus

1 reference

12 December 2020

Measurement of receptor-stimulated guanosine 5'-O-(gamma-thio)triphosphate binding by G proteins

1 reference

12 December 2020

An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis

1 reference

12 December 2020

The 5HT2 receptor defines a family of structurally distinct but functionally conserved serotonin receptors

1 reference

12 December 2020

Allosteric regulation by oleamide of the binding properties of 5-hydroxytryptamine7 receptors

1 reference

12 December 2020

Structural requirements for 5-HT2A and 5-HT1A serotonin receptor potentiation by the biologically active lipid oleamide

1 reference

12 December 2020

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

1 reference

12 December 2020

10.1007/S11064-005-6978-1

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference